WG1: Microbiome and mobile antibiotic resistome in treated wastewater and in downstream environments

 


Objectives:


  • Propose the standardization of the procedures used for antibiotic-resistant bacteria and genes (ARB&Gs) detection and quantification in water and soil samples
  • Identify most prevalent and/or hazardous ARB&ARG with ability to persist, spread and proliferate after wastewater disposal, including under wastewater reuse scenarios
  • Assess the fate, whenever possible quantitatively, of ARB&ARG discharged in treated wastewater and released in surface water or soils
  • Identify the conditions favoring ARB&Gs persistence or proliferation


WG2: Uptake and translocation of organic microcontaminants and ARB&ARG in crops

 


Objectives:


  • Consolidate knowledge on the uptake and translocation of microcontaminants and ARB&Gs in crops
  • Identify the main physicochemical characteristics affecting the behavior of the various microcontaminants and ARB&Gs with regard to uptake and translocation
  • Develop a set of recommendations regarding the minimization of biomagnifications processes and environmental and human health impacts associated with wastewater reuse


WG3: Effect-based bioassays required for wastewater reuse schemes

 


Objectives:


  • Assessment of the existing information available in the literature with regard to biological effects and wastewater
  • Identification of potential relationships between the physicochemical characteristics of the wastewater and biological effects
  • Determination of the most appropriate and relevant to the reuse practice bioassays and/or bioassay battery to be applied for wastewater quality evaluation
  • Propose the harmonization of the procedures used for this purpose harmonised procedures for implementing the selected bioassays


WG4: Technologies efficient/economically viable to meet the current wastewater reuse challenges

 


Objectives:


  • Consolidate knowledge on the fate of microcontaminants during treatment (conventional and advanced treatment)
  • Assess the fate of ARB&ARG during biological processes (e.g., CAS, MBR, MBBR) and characterize removal mechanisms (in collaboration with WG1)
  • Assess the effect of AOPs on ARB&ARG and the subsequent risk for effluent reuse related to oxidation transformation products and residual ARB&ARG release (in collaboration with WG2)
  • Assess the economical feasibility of AOPs compared to that of more conventional treatment processes/technologies in wastewater reuse scenarios
  • Identify the combinations (and economical feasibility) between biological, advanced treatment and required reuse infrastructure in terms of global efficiency/compliance with standard parameters (e.g., BOD, COD, N, P etc.) and contaminants of emerging concern including ARB&ARG


WG5: Risk assessment and policy development

 


Objectives:


  • Develop quality criteria for selected contaminants of emerging concern and ARB&ARG for wastewater reuse
  • Propose a battery of assays for wastewater evaluation for reuse purposes
  • Develop a risk assessment framework for wastewater reuse purposes
  • Propose guidelines/suggestions on possible technologies and systems able to produce wastewater of quality in compliance to the quality criteria to be set (with respect to ARB&ARG, biological risks, etc).
  • Overcome existing barriers in the field of wastewater reuse and valorize wastewater as a non-conventional water resource